Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Down 99.6% in March

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,800 shares, a decrease of 99.6% from the February 28th total of 499,900 shares. Based on an average trading volume of 7,236,000 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Performance

Shares of Enzolytics stock traded up $0.00 on Wednesday, hitting $0.00. The stock had a trading volume of 252,908 shares, compared to its average volume of 5,156,214. Enzolytics has a one year low of $0.00 and a one year high of $0.01.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.